The diminishing returns on increasing amounts of capital employed by La-Z-Boy is a concern. If these trends persist, there might be better investment opportunities elsewhere.
The company's Q3 results missed Wall Street's estimates, indicating weak business quality. With an annualized revenue growth rate of 3.7% over the last five years and declines of 3.2% over the last two years, its cash profitability is mediocre and expected to fall further.
La-Z-Boy is undervalued, presenting a potential opportunity to accumulate more holdings. The current share price doesn't fully reflect the company's future outlook, suggesting it's not too late to buy LZB. Consider other factors like management's track record before investing.
La-Z-Boy's lower P/E ratio is due to its weaker forecast growth. Investors' hesitance about earnings improvement is reflected in the low P/E ratio, suggesting limited share price growth in the near future.
レイジーボーイに関するコメント
...
In reaction to earnings/guidance:
• $レイジーボーイ(LZB.US)$ +6.7%, $インチュイト(INTU.US)$ +5.8%, $ペイコーHCM(PYCR.US)$ +3.3%, $II-VI Inc(IIVI.US)$ +3.3%, $ダイコム インダストリーズ(DY.US)$ +2.2%
Other news:
• $Bed Bath & Beyond Inc(BBBY.US)$+35% (Bed Bath & Beyond shares are trading higher following reports suggesting the company secured a loan deal.)
• $Farfetch(FTCH.US)$ +18.2% (Farfetch, Richemont and Alabbar to partner in YOOX NET-A-PORTER)
...
• $ケザー ライフ サイエンシズ(KZR.US)$ +92% (announces positive top line results from the MISSION Phase 2 trial)
• $ストゥロ バイオファーマ(STRO.US)$ +24.5% (Sutro Biopharma and Astellas to collaborate to advance novel immunostimulatory antibody-drug conjugates)
• $セラゴン ネットワークス(CRNT.US)$ +17.7% (AVNW to acquire all shares of CRNT that it does not already own for $2.80/sh)
• $トリップ・ドット・コム・グループ(TCOM.US)$ +15.6% (In reaction to earnings/guidance)
• $アピックス メディカル(APYX.US)$ +8% (anno...
• $レイジーボーイ(LZB.US)$ +9.3% (In reaction to earnings/guidance)
• $エナンタ ファーマシューティカルズ(ENTA.US)$ +6.7% (ENTA files patent infringement lawsuit against $ファイザー(PFE.US)$)
• $イケナ オンコロジー(IKNA.US)$ +6.6% (granted Fast Track designation for IK-930)
• $ブリッジバイオ ファーマ(BBIO.US)$ +6.4% (Announces Early Positive Data for BBP-812)
• $クリスタル バイオテック(KRYS.US)$ +5% (submits Biologies License Application to FDA seeking approval of B-V...
Tue: Existing home sales. $アマゾン ドット コム(AMZN.US)$ MARS event kick-off. Earnings from $レナー A(LEN.US)$ $レイジーボーイ(LZB.US)$
Wed: Powell testimony. Earnings from $ウィニベーゴ インダストリーズ(WGO.US)$ $KB ホーム(KBH.US)$
Thu: More Powell. Markit PMIs. Earnings from $フェデックス(FDX.US)$ $ダーデン レストランツ(DRI.US)$ $来爱德(RAD.US)$
Fri: New home sales. $カーマックス(KMX.US)$ earnings
$S&P 500 Index(.SPX.US)$ $NYダウ(.DJI.US)$ $Nasdaq Composite Index(.IXIC.US)$
まだコメントはありません